TORCH Profile IgG & IgM 10 Parameters

A Toxoplasma gondii - IgG test measures the presence of immunoglobulin G (IgG) antibodies specific to the Toxoplasma gondii parasite in the blood. These antibodies indicate a previous (past) exposure to the parasite. The presence of IgG antibodies indicates that you have had an infection, but it does not tell when. A high avidity in the IgG avidity test strongly suggests the infection happened more than 4 months ago. However, a low avidity result alone cannot be used to diagnose when the infection occurred, and further clinical evaluation is needed.

In general, having IgG antibodies to Toxoplasma gondii suggests a certain level of protection, but the effectiveness and duration of this protection can depend on factors such as the individual’s overall health, the strain of the parasite, and other immune-related considerations. 

A Toxoplasma gondii - IgM test measures the presence of IgM antibodies in the blood, indicating recent or acute infection with the Toxoplasma gondii parasite. These antibodies are part of the body’s immune response and are produced when an individual is exposed to the parasite. These antibodies are the first to appear after being exposed to the parasite and may persist for up to 18 months post-infection. This test provides valuable information about recent exposure to Toxoplasma gondii, helping in the diagnosis and management of infections, especially in cases where timely detection is crucial.

The Rubella Virus - IgG test measures the presence of Immunoglobulin G (IgG) antibodies specific to the rubella virus in an individual's blood. IgG antibodies are indicative of previous exposure or vaccination against rubella. This test helps assess an individual’s immunity status to the virus. If the IgG antibodies are detected, it suggests that the individual has either been vaccinated against rubella or has had a previous infection, leading to the development of immune protection. 

The Rubella Virus - IgM test determines the presence of Immunoglobulin M (IgM) antibodies in the blood against Rubella virus. IgM antibodies are the first line of defense produced by the immune system in response to a recent infection. Therefore, this test is crucial for diagnosing acute or recent rubella infections. 

In acute primary infection during pregnancy, IgM may be detected 4-15 days after the rash appears. The IgM levels begin to decline after 36 -70 days and may last up to 180 days in some cases.

The Herpes Simplex Virus 1 IgM test detects the presence of IgM antibodies that are produced as a body's initial response to an HSV-1 infection. They are critical in the initial control of the virus. IgM antibodies may take up to 10 days to develop. Also, these antibodies are usually present in higher concentrations shortly after infection and eventually decrease after some time (7-10 days). Therefore, the presence of HSV-1 IgM antibodies is a strong indication of recent exposure and primary infection.

Early detection allows doctors to detect symptoms quickly and provide necessary medical interventions to individuals suffering from HSV infection, leading to better outcomes and improved quality of life.

A Herpes Simplex Virus 1 IgG test determines the presence of IgG antibodies against HSV-1 in response to the Herpes infection. The body begins to make IgG antibodies around 18 to 21 days after the exposure of the virus and remains in the body for life. The presence of IgG antibodies generally indicates past exposure and immunity against herpes infection. Getting tested helps manage herpes infection and prevent it from spreading further as the HSV-1 remains dormant in the body after the initial infection and can reactivate at various times, leading to recurrent outbreaks.

A Cytomegalovirus IgG Antibody test measures the presence of IgG antibodies in the blood, indicating a previous CMV infection. IgG antibodies are produced several weeks after the initial CMV infection. IgG levels rise during the active infection, then stabilize as the CMV infection resolves and the virus becomes inactive. Once exposed to CMV, you will have some measurable amount of CMV IgG antibody in your blood for the rest of your life, which provides protection from getting another primary infection (immunity). However, if you have a weak immune system, the virus can reactivate and cause serious symptoms or organ damage.

A Cytomegalovirus IgM Antibody test measures the presence of Immunoglobulin M (IgM) antibodies in the blood, specifically targeting the CMV. IgM antibodies are produced by the body first in response to a CMV infection. They can be detected in the blood within a week or two after the initial exposure. IgM levels rise for a short time, then decline and usually fall below detectable levels after a few months. IgM antibody levels rise again when latent CMV is reactivated.

Elevated levels of CMV IgM antibodies indicate an ongoing infection or recent exposure to the virus. Understanding the presence of IgM antibodies helps doctors diagnose and manage CMV infections effectively. 

A Herpes Simplex Virus 2 IgG test looks for the presence of IgG antibodies against HSV-2  in response to the Herpes infection. IgG antibodies are the most frequent type of antibody, which are developed around 18 to 21 days after the virus invades the body and remains in the body for life. Thus, the presence of IgG antibodies typically means an individual has been infected with the HSV-2 at some point. Detection of HSV-2 infection allows doctors to provide necessary support and guidance to individuals suffering from genital herpes, leading to better treatment outcomes and improved quality of life.

The Herpes Simplex Virus 2 IgM test detects the presence of IgM antibodies that are produced against an infection caused by herpes simplex virus 2 (HSV-2). IgM antibodies specific for HSV-2 are present only for a relatively short period of time. They are the first antibodies to form after the infection and are excellent markers for the presence of a recently acquired or active disease. Also, these antibodies are usually present in higher concentrations shortly after infection and eventually decrease after some time (7-10 days).